Effects of a short-acting insulin analog (insulin lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 47, Issue 4, 1998, Pages 371-376

  Caixàs, Assumpta ^b   Ṕerez, Antonio ^a   Payés, Amalia ^b   Otal, Carles ^b   Carreras, Gemma ^b   Ordóñez Llanos, Jordi ^b   Reviriego, Jesús ^b   Anderson, James H ^b   De Leiva, Alberto ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEMOGLOBIN ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN TREATMENT; INTENSIVE CARE; LIPID METABOLISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031919461     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90045-2     Document Type: Article

References (37)

1. Lewis GF, Steiner GS: Triglyceride-rich lipoproteins in diabetes, in Draznin B, Eckel RJ (eds): Diabetes and Atherosclerosis. Molecular Basis and Clinical Aspects. New York, NY, Elsevier, 1993, pp 39-58
2. Fielding CJ: Reverse cholesterol transport, lecithin:cholesterol acyltransferase, and cholesteryl ester transfer in insulin-dependent and non-insulin-dependent diabetes mellitus, in Draznin B, Eckel RH (eds): Diabetes and Atherosclerosis. New York, NY, Elsevier, 1993, pp 103-118
3. James RW, Pometta D: Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes 39:1158-1164, 1990
4. Griffin BA, Freeman DJ, Tait GW, et al: Role of plasma triglyceride in the regulation of plasma low density (LDL)( subtractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253, 1994
5. Long HB, Baker JC, Belagale RM, et al: Human insulin analogs with rapid onset and short duration of action, in Smith JA, Rivier JE (eds): Peptides XII: Chemistry and Biology (Proceedings of the 12th American Peptide Symposium). Leiden, The Netherlands, Escom, 1992, pp 88-90
6. Howey DC, Bowsher RR, Brunelle RL, et al: [Lys (B28), Pro (B29)] -Human insulin. A rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
7. Ter Braak EW, Bianchi R, Erckelens DW: Faster, shorter and more profound action of Lys (B28), Pro (B29) human insulin analogue compared to regular insulin irrespective of the site of injection. Diabetes 42:207A, 1993 (suppl 1, abstr)
8. Woodworth J, Bowsher R, Howey D, et al: Pharmacokinetic and pharmacodynamic comparison of [LysB28, ProB29] human insulin to Humulin Regular. Pharm Res 9:S292, 1992 (suppl 10, abstr)
9. Woodworth J, Howey D, Bowsher R, et al: [Lys (B28), Pro (B29)] Human insulin: Dose-ranging vs Humulin Regular. Diabetes 42:54A, 1993 (suppl 1, abstr)
10. Pampanelli S, Torlone E, Lalli C, et al: Improved postprandial metabolic control after injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care 18:1452-1459, 1995
11. Garg SK, Carmain JA, Braddy KC, et al: Pre-meal insulin analogue Lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
12. Fontanals-Ferrer N, Serrat-Serrat J, Sorribas-Vivas A, et al: Quick method of determining lipoproteins, including those of intermediate density, in serum. Clin Chem 34:1753-1757, 1988
13. Griffin BA, Caslake MJ, Yip B, et al: Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83:59-67, 1990
14. Sánchez-Quesada JL, Pérez A, Caixàs A, et al: Electronegative low density lipoprotein subform is increased in patients with shortduration IDDM and is closely related to glycaemic control. Diabetologia 39:1469-1476, 1996
15. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
16. Ramírez I, Kryski AJ, Ben-Ze-ev O, et al: Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart. Biochem J 232:229-236, 1985
17. Lopes-Virella MF, Wohltmann HJ, Mayfield RK, et al: Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients: A longitudinal study. Diabetes 32:20-24, 1983
18. Kobbah M, Vessby B, Tuvemo T: Serum lipids and apolipoproteins in children with type I diabetes during the first two years of disease. Diabetologia 31:195-200, 1988
19. Taskinen MR: Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 4:743-775, 1990
20. Lahdenperä S, Syvänne M, KahriJ, et al: Regulation of LDL particle size distribution in NIDDM and coronary heart disease: Importance of serum triglycerides. Diabetologia 39:453-461, 1996
21. Ruotolo G, Parlavecchia M, Galimberti G, et al: Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care 17:6-12, 1994
22. Rivellese A, Riccardi G, Romano R, et al: Presence of very low density lipoprotein compositional abnormalities in type 1 (insulindependent) diabetic patients: Effects of blood glucose optimisation. Diabetologia 31:884-888, 1988
23. Georgopoulos A, Applebaum-Bowden D, Margolis S: Improved glycemic control lowers plasma apolipoprotein E and triglyceride levels following ingestion of a fat load in insulin-dependent diabeic subjects. Metabolism 37:837-843, 1988
24. Georgopoulos A, Rosengard AM: Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: Effects of sex. Metabolism 38:781-789, 1989
25. Winocour PH, Durrington PN, Bhatnagar D, et al: Abnormalities of VLDL, IDL and LDL characterize insulin-dependent diabetes mellitus. Arterioscler Thromb 12:920-928, 1992
26. Bagdade JD, Helve E, Taskinen MR: Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism 40:445-449, 1991
27. Bagdade JD, Dunn FL: Effects of insulin treatment on lipoprotein composition and function in patients with IDDM. Diabetes 4:107-110, 1992 (suppl 2)
28. Dullaart RP, Groener JE, Dikkeschei LD, et al: Increased cholesteryl ester transfer activity in complicated type I (insulindependent) diabetes mellitus, its relationship with serum lipids. Diabetologia 32:14-19, 1989
29. Patti L, Romano G, Di Marino L, et al: Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: Could plasma lipase activities play a role? Diabetologia 36:155-160, 1993
30. Patti L, Di Marino L, Maffettone A, et al: Very low density lipoprotein subfraction abnormalities in IDDM patients: Any effect of blood glucose control? Diabetologia 38:1419-1424, 1995
31. Howard BV: Lipoprotein metabolism, in diabetes mellitus. J Lipid Res 28:613-628, 1987
32. Nikkila EA, Hormila P: Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes 27:1078-1086, 1978
33. Dunn FL, Thompson MJ, Eckel RH, et al: Intraperitoneal insulin therapy in IDDM normalizes very low density lipoprotein composition independent of improved glycemic control. Diabetes 41:101A, 1992 (abstr)
34. Laakso M, Sarlund H, Ehnholm C, et al: Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia 30:703-706, 1987
35. Nikkila EA, Huttunen JK, Ehnholm C: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes 26:11-21, 1977
36. Dunn FL, Pietri A, Raskin P: Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med 95:426-431, 1981
37. Pietri A, Dunn FL, Grundy SM, et al: The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus. Diabetes 32:75-81, 1983